Every day, Global University Venturing rounds up investments from across the university innovation ecosystem in its deal net.
BenchSci, a Canada-based drug discovery analysis software developer spun out of University of Toronto, has attracted C$63m ($49.5m) in a series C round co-led by Inovia Capital and TCV, according to Betakit. Gradient Ventures, internet technology provider Google’s artificial intelligence fund, also took part in the round, as did financial services group Fidelity’s F-Prime Capital…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Talking Tech Transfer interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
